It is clear that mutations in histone-modifying enzymes like KMT2D, CREBBP, P300, and EZH2 are some of the most common in DLBCL and that they contribute directly to its molecular pathogenesis. This evidence concerns the gene CREBBP and diffuse large B-cell lymphoma.